Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

1 hr ago | TheStreet.com

Why GlaxoSmithKline (GSK) Stock Is Higher Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Mozilla, TheStreet, Financial Markets

3 hrs ago | Live Charts

GlaxoSmithKline may spin off consumer healthcare arm - report

British drug giant GlaxoSmithKline may spin off its consumer health division as it tries to get to grips with increasing competition for its drugs and Chinese bribery allegations, it was reported on Monday.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Healthcare Industry

8 hrs ago | Seeking Alpha

Glaxo open to spinning off consumer healthcare business

GlaxoSmithKline's chief exec has announced the possibility of spinning off the group's consumer healthcare business in the future, should it offer more value as a standalone company.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Sat Jul 26, 2014

Barron's

At Theravance, It's Hard to Breathe Easy

Investors dumped shares of Theravance last week, sending the stock down 18% to $22.94, after GlaxoSmithKline, which distributes Theravance's flagship pulmonary-disorder treatments, reported that sales of the products fell dramatically below expectations in the latest quarter.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

GlaxoSmithKline plc's "Underperform" Rating Reaffirmed at Zacks

's stock had its "underperform" rating restated by Zacks in a research report issued to clients and investors on Friday.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

Fri Jul 25, 2014

The Motley Fool

Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline

Let's take a look at today's top stories in biotech and health care. Keep an eye out for AbbVie ( AbbVie tops estimates in the second quarter AbbVie released its second-quarter results this morning, posting an Adjusted EPS of $0.82 on $4.926 billion in revenue.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

PE Hub

Atox Bio raises $23 mln to fund flesh-eating bacteria treatment: Reuters

Israel-based Atox Bio , a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One , the healthcare venture capital fund of GlaxoSmithKline .

Comment?

Related Topix: Flesh Eating Bacteria, Health, Biotech, GlaxoSmithKline, Healthcare Industry

Thu Jul 24, 2014

AlertNet

EXCLUSIVE-Allegations of GSK corruption spread to Syria

In this 2008 file photo, signage is pictured on the company headquarters of GlaxoSmithKline in west London REUTERS/Toby Melville LONDON, July 24 - GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's ... (more)

Comment?

Related Topix: Syria, World News, Middle East, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Drugs

BioSpace

GlaxoSmithKline CEO And CFO Interviewed On Q2 2014 Results And Strategy Update

Global healthcare company GSK reports Q2 results reflecting a business that is facing currency headwinds, increased price competition and supply disruptions to its Consumer business.

Comment?

Related Topix: Biotech

The Motley Fool

Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure?

U.S. sales of aging blockbuster Advair dropped by an astounding 19%, and Breo and Anora Ellipta, which have been hailed as potential blockbusters, turned in disappointing sales .

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

Voice of America

GSK Seeks Approval for World's First Malaria Vaccine

GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.

Comment?

Related Topix: Medicine, Malaria, Health, Biotech

BioSpace

Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Announces Record...

Ligand Partner GSK Announces Record Quarterly Promactaa /Revoladea Revenue of $92 Million Strong quarterly growth driven by sales in US, EU and Emerging Markets SAN DIEGO-- --Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline plc has announced global revenue for Promactaa /Revoladea for the second quarter ended ... (more)

Comment?

Related Topix: Biotech, Medicine, Ligand Pharmaceuticals, Healthcare Industry, GlaxoSmithKline

Reuters

GSK seeks approval for world's first malaria vaccine

GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.

Comment?

Related Topix: Malaria, Medicine, Health, GlaxoSmithKline, Biotech, Healthcare Industry

Minyanville

Pre-Market: LG Profits Fall By Over 50%; Sony Plans to Increase Image Sensor Production

Stock futures pointed toward a higher open on Wednesday. Before the opening bell, Dow Jones futures rose 0.06% to 17,043.

Comment?

Related Topix: Apple, Startups, Microsoft, LG Display Co, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, EPS

Wed Jul 23, 2014

Seeking Alpha

GlaxoSmithKline's (GSK) CEO Andrew Wittyon Q2 2014 Results - Earnings Call Transcript

Good afternoon, welcome to today's call to everybody. GSK's performance in the second quarter provides evidence of the very significant changes are taking place in the Group's portfolio.

Comment?

Related Topix: Biotech

Business Journal

As Advair sales decline, GSK looks to transition Zebulon to new products

New Chief Executive of GlaxoSmithKline, Andrew Witty, poses for photographers outside the company headquarters in west London July 21, 2008.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

Reuters

UK fraud office liaising with China on GSK bribery case

Britain's fraud office is working with authorities in China in a first for such Anglo-Chinese cooperation as it carries out its own investigation into alleged corruption at drugmaker GlaxoSmithKline , said in an interview with Reuters on Wednesday.

Comment?

Related Topix: Biotech

Forbes.com

Wednesday's ETF with Unusual Volume: PPH

The Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday, with over 377,000 shares traded versus three month average volume of about 101,000.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Financial Markets

SchaeffersResearch.com

Options Radar: Electronic Arts Inc., GlaxoSmithKline, and Xilinx, Inc.

According to sources, the downturn can be attributed to the company's plans to delay the release of its highly anticipated title, Battlefield: Hardline .

Comment?

Related Topix: Startups, Electronic Arts, Xilinx, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Day Trading, Financial Markets, Personal Finance

Business Journal

Biopharma industry at highest risk for employee turnover

A new survey reveals it might be easier for companies in the biopharma industry to poach employees from one another, especially among employees who view themselves as underpaid.

Comment?

Related Topix: Research Triangle Park, NC, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Merck & Co., Merck

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••